Add BrightSurf on Google Email

Researcher hits bulls-eye for antibiotic target

A Purdue University researcher has determined the structure of a protein that controls starvation response in E. coli, which can be targeted to combat bacterial infections. The protein is found in numerous harmful bacteria and is an excellent antibiotic target due to its high processivity.

SourcePurdue University·JournalStructure·DateAug 21, 2006

Study finds MRSA most common cause of skin infections in patients presenting in nation's ER's

MRSA is the most common cause of skin and soft-tissue infections among patients presenting in emergency rooms across the country, according to a UCLA study. The infection was found to be resistant to commonly used antibiotics, emphasizing the need for clinicians to culture infections and prescribe effective medications.

SourceUniversity of California - Los Angeles·JournalNew England Journal of Medicine·DateAug 16, 2006

Eliminating blindness the safe way

A trachoma control programme using the SAFE strategy, which combines surgery, antibiotics, facial cleanliness, and environmental change, significantly reduced active trachoma prevalence by 92% in two districts. The study highlights the potential for this approach to also benefit other communicable diseases like diarrhoea and pneumonia.

SourceThe Lancet_DELETED·JournalThe Lancet·DateAug 10, 2006

Much needed new antibiotic in fight against 'superbugs'

The launch of Tygacil (tigecycline) in the UK marks a significant step forward in the fight against antibiotic-resistant bacteria, including MRSA and Escherichia Coli. The new antibiotic has been developed to overcome common mechanisms of resistance and offers a single effective therapy for complicated skin and soft tissue infections.

Biomarker reduces length of antibiotic treatment

A biomarker named procalcitonin can reduce the length of antibiotic treatment for community-acquired pneumonia (CAP) patients. Studies found that lower procalcitonin levels could shorten antibiotic use by an average of seven days, but guidelines suggest shorter courses and caution against over-reliance on this marker.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateJun 30, 2006

Reduced antibiotic prescribing is associated with increased hospital admissions

A study published in the Journal of the Royal Society of Medicine found that reducing antibiotic prescribing was associated with an increase in hospital admissions for respiratory infections. The research analyzed data from over 15 million hospitalizations and suggested that limiting antibiotic use may not be beneficial in all cases.

SourceRoyal Society of Medicine·JournalJournal of the Royal Society of Medicine·DateJun 21, 2006

New treatment for food poisoning

A new treatment using fosfomycin has shown promise in treating Listeria infections, which cause severe food-borne diseases. The drug was ineffective in laboratory tests but proved effective in the body, highlighting the need to revise testing methods.

SourceUniversity of Bristol·JournalNature Medicine·DateMay 11, 2006

Vaccine combined with short-term postexposure antibiotics protects monkeys from inhalational anthrax

Researchers found that a vaccine combined with short-term antibiotic treatment can protect nonhuman primates from inhalational anthrax. The study suggests that this combination may be crucial for successful defense against large-scale anthrax attacks, minimizing the risk of adverse events and improving public health management.

SourceUS Army Medical Research Institute of Infectious Diseases·JournalProceedings of the National Academy of Sciences·DateMay 1, 2006

Aspirin shows promise in combating a common, antibiotic-induced hearing loss

Researchers found that aspirin significantly reduces the risk of hearing loss when paired with gentamicin, a commonly used antibiotic. The study, conducted in China and published in the New England Journal of Medicine, showed a 75% lower incidence of hearing loss in patients given aspirin compared to those receiving placebos.

SourceMichigan Medicine - University of Michigan·JournalNew England Journal of Medicine·DateApr 26, 2006

Study: Newer antibiotic more effective at treating elders' pneumonia

A study led by Dr. Antonio Anzueto found that the newer medication moxifloxacin HCI is more effective at treating community-acquired pneumonia (CAP) in elderly patients, with a recovery rate of 97.9%, compared to 90% for the standard medication levofloxacin. The study also assessed cardiac safety and found both treatments to be safe.

SourceUniversity of Texas Health Science Center at San Antonio·JournalClinical Infectious Diseases·DateJan 24, 2006

Jefferson scientists design method to fight artificial implant infections with antibiotics

Researchers at Jefferson Medical College have developed a bonding method to create a permanent chemical bond between antibiotics and titanium, allowing it to kill bacteria and prevent infection. This technique has the potential to combat implant-related infections by creating an antibiotic surface that prevents infection from starting.

SourceThomas Jefferson University·JournalChemistry & Biology·DateSep 23, 2005

Troubling trends converge

Researchers report a disturbing convergence of drug-resistant bacteria and virulent new strains of Staph. aureus, leading to severe illness and death in previously healthy children. The study highlights the need for better treatments and a vaccine to combat this growing threat.

SourceUniversity of Chicago Medical Center·JournalNew England Journal of Medicine·DateSep 22, 2005

New treatment option for childhood cholera

A new single-dose ciprofloxacin treatment has been shown to be effective in treating childhood cholera, with 60% of cases cured within 48 hours. However, the new treatment is less effective at eradicating the cholera bacteria from stool compared to a 12-dose course of erythromycin.

SourceThe Lancet_DELETED·JournalThe Lancet·DateSep 13, 2005

Bon Appétit Management Company

Bon Appétit is recognized for its 'Circle of Responsibility' program, incorporating environmentally responsible and sustainable practices such as farm-to-fork sourcing, organic food options, and fair trade choices. The company's commitment to sustainability promotes the health of people and the environment.

Agricultural antibiotic use contributes to 'super-bugs' in humans

Antibiotic-resistant bacteria can be transmitted from animals to humans through contaminated food and handling practices. The European Union ban on agricultural antibiotics has led to a decline in resistant bacteria, suggesting that transmission from agriculture can have a greater impact on human populations than hospital transmission.

SourcePLOS·JournalPLOS Medicine·DateJul 4, 2005